(Q44318416)

1 December 2017

title

Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma (English)

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

5 November 2022

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

5 November 2022

2

H. J. Schmoll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

author name string

A. Harstrick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

C. H. Köhne-Wömpner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

L. Bergmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

U. Lammers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

J. Hohnloser

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

G. Dölken

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

P. Reichhardt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

W. Siegert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

F. Natt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1710481

5 November 2022

publication date

1 March 1991

1 reference

full work available at URL

1 December 2017

http://annonc.oxfordjournals.org/cgi/content/abstract/2/3/197

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1710481

https://api.elsevier.com/content/article/PII:S092375342031423X?httpAccept=text/xml

5 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

https://api.elsevier.com/content/article/PII:S092375342031423X?httpAccept=text/plain

5 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

http://academic.oup.com/annonc/article-pdf/2/3/197/676767/2-3-197.pdf

5 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

5 November 2022

1 reference

1 December 2017

volume

2

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

197-202

1 reference

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group

5 November 2022

2

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)

5 November 2022

3

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up

5 November 2022

4

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Multivariate analysis of prognostic variables in patients with disseminated non-seminomatous testicular cancer: results from an EORTC multi-institutional phase III study

5 November 2022

6

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Prognostic factors for favorable outcome in disseminated germ cell tumors

5 November 2022

7

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

5 November 2022

9

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

The role of ifosfamide in testicular cancer

5 November 2022

10

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Activity of cytostatic drugs in two heterotransplanted human testicular cancer cell lines with different sensitivity to standard agents

5 November 2022

11

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Nonparametric Estimation from Incomplete Observations

5 November 2022

13

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors

5 November 2022

15

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

5 November 2022

16

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

VAB-6 as initial treatment of patients with advanced seminoma

5 November 2022

17

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis

5 November 2022

18

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Further advances in the management of malignant teratomas of the testis and other sites

5 November 2022

19

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors

5 November 2022

20

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors

5 November 2022

21

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours

5 November 2022

22

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057904

5 November 2022

Identifiers

1 reference

1 December 2017

1 reference